Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable ...
Yahoo Finance6d
Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?
In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best gene-editing stocks to buy. Gene editing is an advanced medical ...
Vertex Pharmaceuticals (VRTX) Gets a Hold from Bernstein
In a report released today, William Pickering from Bernstein maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...
Nasdaq9d
Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know
Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...
Vertex Pharmaceuticals: A Look At Their Pain Therapy Program
Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Vertex Pharmaceuticals Inc. closed 5.23% below its 52-week high of $519.88, which the company achieved on November 8th.